Endre A. Balazs
Corporate Officer/Principal chez The Trustees of Columbia University in The City of New York
Profil
Endre A.
Balazs was the founder and held the position of Chief Executive Officer at Biomatrix, Inc. from 1981 to 2011.
He is currently a Professor-Emeritus at The Trustees of Columbia University in The City of New York.
Dr. Balazs received a doctorate degree from Budapest University of Technology & Economics in 1943.
Postes actifs de Endre A. Balazs
| Sociétés | Poste | Début |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Anciens postes connus de Endre A. Balazs
| Sociétés | Poste | Fin |
|---|---|---|
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ. | Fondateur | 11/05/2011 |
Formation de Endre A. Balazs
| Budapest University of Technology & Economics | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Biomatrix, Inc.
Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ. | Health Technology |
